Astrocytoma - Pipeline Review, H2 2011

Global Markets Direct
August 31, 2011
152 Pages - SKU: GMD6506158
Epilepsy - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
Epilepsy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2014’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative  |  read more...
USD 2,000
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
8/20/2014 | published by: GBI Research
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, Glioblastoma Multiforme  |  read more...
USD 4,995
Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Dementia Associated With Alzheimer's Disease’s therapeutic pipeline. This report  |  read more...
USD 2,000
Narcolepsy - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Narcolepsy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Narcolepsy - Pipeline Review, H2 2014’, provides an overview of the Narcolepsy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Narcolepsy, complete with comparative  |  read more...
USD 2,000
Opium (Opioid) Addiction - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
Opium (Opioid) Addiction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Opium (Opioid) Addiction - Pipeline Review, H2 2014’, provides an overview of the Opium (Opioid) Addiction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Tourette Syndrome - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Tourette Syndrome - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Tourette Syndrome - Pipeline Review, H2 2014’, provides an overview of the Tourette Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tourette  |  read more...
USD 2,000
Anxiety Disorders - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
Anxiety Disorders - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2014’, provides an overview of the Anxiety Disorders’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anxiety  |  read more...
USD 2,000
Dysthymia Global Clinical Trials Review, H1, 2014
6/30/2014 | published by: GlobalData
Dysthymia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Dysthymia Global Clinical Trials Review, H1, 2014 provides data on the Dysthymia clinical trial scenario. This report provides elemental information and data relating to the  |  read more...
USD 2,500
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014
6/30/2014 | published by: GlobalData
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014 provides data on the Guillain-Barre Syndrome clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Generalized Seizures Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Generalized Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014 provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!